Skip to main content

Table 1 Association between clinical data and NLR/PLR

From: Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study

clinical parameters n NLR PLR
LNLR
(n = 50)
HNLR
(n = 46)
p-value LPLR
(n = 30)
HPLR
(n = 66)
p-value
Age (year)     0.447    0.823
  ≤ 17 56 31 25   18 38  
  > 17 40 19 21   12 28  
Sex     0.959    0.165
 Male 54 28 26   20 34  
 Female 42 22 20   10 32  
Tumor location     0.949    0.363
 Tibia 40 28 12   16 24  
 Femur 44 30 14   10 34  
 Others 12 8 4   4 8  
Tumor size (cm3) 195.37 ± 8.74 171.37 ± 12.94 218.34 ± 11.24 0.034 173.22 ± 10.54 201.97 ± 15.24 0.041
Enneking stage     0.024    0.321
 I 28 18 10   10 18  
 II 46 26 20   16 30  
 III 22 6 16   4 18  
Subtype     0.202    0.362
 Osteoblastic 58 34 24   15 43  
 Chondroblastic 22 8 14   9 13  
 Others 16 8 8   6 10  
ALP     0.013    0.763
 Elevated 50 20 30   16 34  
 Normal 46 30 16   14 32  
ESR     0.478    0.352
 Elevated 70 38 32   20 50  
 Normal 26 12 14   10 16  
CRP     0.148    0.161
 Elevated 64 38 26   17 47  
 Normal 32 14 18   13 19  
Mononuclear(109/L) 0.64 ± 0.28 0.58 ± 0.23 0.66 ± 0.29 0.376 0.64 ± 0.20 0.65 ± 0.31 0.782